Medical trials at Aurora Research Institute uncover lifesaving news for leukemia patients

A prolonged life and fewer side effects are among the benefits for leukemia patients on a specific drug regimen, according to two new clinical trials. The breakthrough findings are expected to immediately change the treatment for patients with leukemia. Both trials Aurora Research Institute studied the anticancer drug called ibrutinib for treating chronic lymphocytic leukemia (CLL). “CLL is the most common leukemia in adults in Western count ries,” said Dr. Rubina Qamar, the principal investigator…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news